De novo cancer in transplant recipients

Transplant Proc. 1996 Jun;28(3):1651-2.
No abstract available

MeSH terms

  • Adult
  • Antilymphocyte Serum / therapeutic use
  • Chi-Square Distribution
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Gastrointestinal Neoplasms / epidemiology
  • Graft Rejection / epidemiology
  • Graft Rejection / therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Kidney Transplantation*
  • Lung Neoplasms / epidemiology
  • Lymphoma / epidemiology
  • Muromonab-CD3 / therapeutic use
  • Neoplasms / epidemiology*
  • Neoplasms / therapy
  • Postoperative Complications*
  • Retrospective Studies
  • Time Factors
  • Uterine Cervical Neoplasms / epidemiology

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3